Navigation Links
NeoStem to Expand Stem Cell Collection Center Network to Florida
Date:5/13/2008

Development Partnership with CelVida Yields First Milestone

NEW YORK, May 13 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that a site has been secured for a new stem cell collection center in Coral Gables, Florida, a suburb of Miami.

Robin Smith, MD MBA, NeoStem's Chairman and Chief Executive Officer commented: "Securing the Florida site for a new collection center in our network is the first major step in building a presence in the Southeast region of the country. Florida is a significant healthcare market offering a dynamic population of both the young and the aging. We are focused on expanding NeoStem's national network of collection centers in major metropolitan areas of the US to drive growth and revenues."

The Florida site is the result of a development agreement with CelVida LLC to join NeoStem's growing national network. CelVida develops and operates stem cell collection centers and related activities, including using NeoStem's proprietary, minimally invasive process.

Chester Amedia, Jr. MD, FACP, founder and President of CelVida LLC, is an interventional nephrologist with extensive business and patient care experience in the fields of disease management and extracorporeal therapies. Dr. Amedia holds the academic rank of Clinical Professor of Internal Medicine at Northeastern Ohio Universities College of Medicine, where he is active in the teaching of medical students. He is a diplomat of the American Board of Internal Medicine with subspecialty certification in nephrology, has been a co-investigator or local coordinator for a number of multicenter research projects, and is a Fellow of the American College of Physicians.

"We are pleased and excited to bring NeoStem to the Miami area to give people the opportunity to proactively have their stem cells collected for preservation and future use," said Dr. Amedia. "CelVida believes this collaboration with NeoStem will provide forward thinking, healthy people in the southeastern United States the opportunity to secure bio-insurance for their medical futures."

About NeoStem, Inc.

NeoStem has a growing nationwide network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's periodic filings with the Securities and Exchange Commission.

Contact:

NeoStem, Inc.

Robin Smith, Chief Executive Officer

T: 212-584-4180

E: rsmith@neostem.com

http://www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
2. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
3. NeoStem to Present at Third Annual Stem Cell Summit in New York City
4. NeoStem Announces NY State License for Adult Stem Cell Collection
5. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
6. Sidec AB Expands Into New Offices
7. Spectral and Toray expand collaboration to include new geographic territories
8. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
9. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
10. Quintiles Consulting Business Expands
11. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
(Date:1/19/2017)... N.J. , Jan. 18, 2017 BD (Becton, Dickinson ... company, announced today that it will host a live webcast of ... 1 p.m. (ET). The webcast can be accessed ... available for replay through Tuesday, January 31, 2017. ... About BD BD is ...
(Date:1/18/2017)... Jan. 18, 2017 Applied BioMath ( ... to drug research and development, today announced that ... and CEO of Applied BioMath, will present at ... Modeling (BAGIM) Meeting on Thursday January 19, 2017 ... , MA.   Dr. Burke,s talk "Quantitative Modeling ...
Breaking Biology Technology:
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
Breaking Biology News(10 mins):